ANP 4.17% 5.0¢ antisense therapeutics limited

ATL1102 Blockbuster drug in 2020 and a Coy maker., page-2

  1. 7,696 Posts.
    lightbulb Created with Sketch. 285
    Sarepta Therapeutics Inc (NASDAQ:SRPT) shares saw strong trading volume on Friday after Cantor Fitzgerald raised their price target on the stock from $175.00 to $211.00. Cantor Fitzgerald currently has an overweight rating on the stock. 10,790,598 shares changed hands during mid-day trading, an increase of 673% from the previous session’s volume of 1,395,266 shares.The stock last traded at $132.05 and had previously closed at $100.47

    A number of other equities analysts have also issued reports on the company. Janney Montgomery Scott upped their target price on Sarepta Therapeutics from $160.00 to $175.00 and gave the company a “buy” rating in a research report on Friday. Leerink Swann upped their target price on Sarepta Therapeutics from $186.00 to $216.00 and gave the company an “outperform” rating in a research report on Friday. Guggenheim assumed coverage on Sarepta Therapeutics in a research report on Friday, November 1st. They issued a “buy” rating and a $183.00 target price on the stock.
    ——-_____________________\\
    So this is the space to be in —DMD..
    Can’t wait for Monday..$$$$

 
watchlist Created with Sketch. Add ANP (ASX) to my watchlist
(20min delay)
Last
5.0¢
Change
0.002(4.17%)
Mkt cap ! $23.46M
Open High Low Value Volume
4.7¢ 5.0¢ 4.7¢ $15.98K 330.3K

Buyers (Bids)

No. Vol. Price($)
2 92669 4.7¢
 

Sellers (Offers)

Price($) Vol. No.
5.0¢ 53531 1
View Market Depth
Last trade - 11.22am 01/04/2020 (20 minute delay) ?
(live)
Last
5.0¢
  Change
0.002 ( 8.70 %)
Open High Low Volume
4.8¢ 5.0¢ 4.8¢ 33151
Last updated 11.19am 01/04/2020 (live) ?
ANP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.